Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. STKE, 2 January 2007
Vol. 2007, Issue 367, p. re1
[DOI: 10.1126/stke.3672007re1]
REVIEWS
How Do MicroRNAs Regulate Gene Expression?
Richard J. Jackson* and
Nancy Standart*
Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Abstract:
Several thousand human genes, amounting to about one-third of the whole genome, are potential targets for regulation by the several hundred microRNAs (miRNAs) encoded in the genome. The regulation occurs posttranscriptionally and involves the ~21-nucleotide miRNA interacting with a target site in the mRNA that generally has imperfect complementarity to the miRNA. The target sites are almost invariably in the 3'-untranslated region of the messenger RNA (mRNA), often in multiple copies. Metazoan miRNAs were previously thought to down-regulate protein expression by inhibiting target mRNA translation at some stage after the translation initiation step, without much effect on mRNA abundance. However, recent studies have questioned these suppositions. With some targets, an increase in the rate of mRNA degradation by the normal decay pathway contributes to the decrease in protein expression. miRNAs can also inhibit translation initiation, specifically the function of the cap-binding initiation factor, eIF4E. Repressed target mRNAs as well as miRNAs themselves accumulate in cytoplasmic foci known as P-bodies, where many enzymes involved in mRNA degradation are concentrated. However, P-bodies may also serve as repositories for the temporary and reversible storage of untranslated mRNA, and reducing the expression (knockdown) of several distinct P-body protein components can alleviate miRNA-mediated repression of gene expression.
Nancy R. Gough (29 September 2009) Sci. Signal.2 (90), ec317.
[DOI: 10.1126/scisignal.290ec317] |Abstract »
PERSPECTIVES
Jason E. Fish and Deepak Srivastava (6 January 2009) Sci. Signal.2 (52), pe1.
[DOI: 10.1126/scisignal.252pe1] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
Nancy R. Gough (8 July 2008) Sci. Signal.1 (27), ec244.
[DOI: 10.1126/scisignal.127ec244] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Epigenetics and Psychostimulant Addiction.
H. D. Schmidt, J. F. McGinty, A. E. West, and G. Sadri-Vakili (2013)
Cold Spring Harb Perspect Med
3, a012047
|Abstract »|Full Text »|PDF »
Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.
M. R. Epis, K. M. Giles, F. C. Kalinowski, A. Barker, R. J. Cohen, and P. J. Leedman (2012)
J. Biol. Chem.
287, 35251-35259
|Abstract »|Full Text »|PDF »
Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing.
A. Dallas, H. Ilves, Q. Ge, P. Kumar, J. Shorenstein, S. A. Kazakov, T. L. Cuellar, M. T. McManus, M. A. Behlke, and B. H. Johnston (2012)
Nucleic Acids Res.
40, 9255-9271
|Abstract »|Full Text »|PDF »
Kinetic signatures of microRNA modes of action.
N. Morozova, A. Zinovyev, N. Nonne, L.-L. Pritchard, A. N. Gorban, and A. Harel-Bellan (2012)
RNA
18, 1635-1655
|Abstract »|Full Text »|PDF »
Differential association of microRNAs with polysomes reflects distinct strengths of interactions with their mRNA targets.
Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver.
J. R. Androsavich, B. N. Chau, B. Bhat, P. S. Linsley, and N. G. Walter (2012)
RNA
18, 1510-1526
|Abstract »|Full Text »|PDF »
A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication.
Y. Chen, A. Shen, P. J. Rider, Y. Yu, K. Wu, Y. Mu, Q. Hao, Y. Liu, H. Gong, Y. Zhu, et al. (2011)
FASEB J
25, 4511-4521
|Abstract »|Full Text »|PDF »
Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365.
M. Papetti and L. H. Augenlicht (2011)
Am J Physiol Gastrointest Liver Physiol
301, G508-G518
|Abstract »|Full Text »|PDF »
Activation of a microRNA response in trans reveals a new role for poly(A) in translational repression.
E. P. Ricci, T. Limousin, R. Soto-Rifo, R. Allison, T. Poyry, D. Decimo, R. J. Jackson, and T. Ohlmann (2011)
Nucleic Acids Res.
39, 5215-5231
|Abstract »|Full Text »|PDF »
Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers.
H. M. Heneghan, N. Miller, O. J. McAnena, T. O'Brien, and M. J. Kerin (2011)
J. Clin. Endocrinol. Metab.
96, E846-E850
|Abstract »|Full Text »|PDF »
Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex.
miR-99 Family of MicroRNAs Suppresses the Expression of Prostate-Specific Antigen and Prostate Cancer Cell Proliferation.
D. Sun, Y. S. Lee, A. Malhotra, H. K. Kim, M. Matecic, C. Evans, R. V. Jensen, C. A. Moskaluk, and A. Dutta (2011)
Cancer Res.
71, 1313-1324
|Abstract »|Full Text »|PDF »
Regulation of Heme Oxygenase-1 Protein Expression by miR-377 in Combination with miR-217.
J. D. Beckman, C. Chen, J. Nguyen, V. Thayanithy, S. Subramanian, C. J. Steer, and G. M. Vercellotti (2011)
J. Biol. Chem.
286, 3194-3202
|Abstract »|Full Text »|PDF »
The GW/WG repeats of Drosophila GW182 function as effector motifs for miRNA-mediated repression.
M. Chekulaeva, R. Parker, and W. Filipowicz (2010)
Nucleic Acids Res.
38, 6673-6683
|Abstract »|Full Text »|PDF »
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
D. Schotte, E. A. M. Lange-Turenhout, D. J. P. M. Stumpel, R. W. Stam, J. G. C. A. M. Buijs-Gladdines, J. P. P. Meijerink, R. Pieters, and M. L. Den Boer (2010)
Haematologica
95, 1675-1682
|Abstract »|Full Text »|PDF »
TIMP3: a physiological regulator of adult myogenesis.
H. Liu, S.-E. Chen, B. Jin, J. A. Carson, A. Niu, W. Durham, J.-Y. Lai, and Y.-P. Li (2010)
J. Cell Sci.
123, 2914-2921
|Abstract »|Full Text »|PDF »
Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease.
H. M. Heneghan, N. Miller, R. Kelly, J. Newell, and M. J. Kerin (2010)
Oncologist
15, 673-682
|Abstract »|Full Text »|PDF »
MicroRNA-370 controls the expression of MicroRNA-122 and Cpt1{alpha} and affects lipid metabolism.
D. Iliopoulos, K. Drosatos, Y. Hiyama, I. J. Goldberg, and V. I. Zannis (2010)
J. Lipid Res.
51, 1513-1523
|Abstract »|Full Text »|PDF »
Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator.
T. M. Bui-Nguyen, S. B. Pakala, D. R. Sirigiri, E. Martin, F. Murad, and R. Kumar (2010)
J. Biol. Chem.
285, 6980-6986
|Abstract »|Full Text »|PDF »
Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3'UTR.
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
Y. Lu, Y. Zhang, H. Shan, Z. Pan, X. Li, B. Li, C. Xu, B. Zhang, F. Zhang, D. Dong, et al. (2009)
Cardiovasc Res
84, 434-441
|Abstract »|Full Text »|PDF »
Evidence of MyomiR network regulation of {beta}-myosin heavy chain gene expression during skeletal muscle atrophy.
J. J. McCarthy, K. A. Esser, C. A. Peterson, and E. E. Dupont-Versteegden (2009)
Physiol Genomics
39, 219-226
|Abstract »|Full Text »|PDF »
MicroRNA-661, a c/EBP{alpha} Target, Inhibits Metastatic Tumor Antigen 1 and Regulates Its Functions.
S. D. N. Reddy, S. B. Pakala, K. Ohshiro, S. K. Rayala, and R. Kumar (2009)
Cancer Res.
69, 5639-5642
|Abstract »|Full Text »|PDF »
An expanded seed sequence definition accounts for full regulation of the hid 3' UTR by bantam miRNA.
Activation of Pattern Recognition Receptor-Mediated Innate Immunity Inhibits the Replication of Hepatitis B Virus in Human Hepatocyte-Derived Cells.
H. Guo, D. Jiang, D. Ma, J. Chang, A. M. Dougherty, A. Cuconati, T. M. Block, and J.-T. Guo (2009)
J. Virol.
83, 847-858
|Abstract »|Full Text »|PDF »
Coordinated Changes in mRNA Turnover, Translation, and RNA Processing Bodies in Bronchial Epithelial Cells following Inflammatory Stimulation.
Y. Zhai, Z. Zhong, C.-Y. A. Chen, Z. Xia, L. Song, M. R. Blackburn, and A.-B. Shyu (2008)
Mol. Cell. Biol.
28, 7414-7426
|Abstract »|Full Text »|PDF »
Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells.
D. Zheng, N. Ezzeddine, C.-Y. A. Chen, W. Zhu, X. He, and A.-B. Shyu (2008)
J. Cell Biol.
182, 89-101
|Abstract »|Full Text »|PDF »
Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells.
J. Chang, J.-T. Guo, D. Jiang, H. Guo, J. M. Taylor, and T. M. Block (2008)
J. Virol.
82, 8215-8223
|Abstract »|Full Text »|PDF »
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies.
J. N. Savas, A. Makusky, S. Ottosen, D. Baillat, F. Then, D. Krainc, R. Shiekhattar, S. P. Markey, and N. Tanese (2008)
PNAS
105, 10820-10825
|Abstract »|Full Text »|PDF »
Computational analysis of miRNA-mediated repression of translation: Implications for models of translation initiation inhibition.
Neutrophil-selective CD18 silencing using RNA interference in vivo.
X. Cullere, M. Lauterbach, N. Tsuboi, and T. N. Mayadas (2008)
Blood
111, 3591-3598
|Abstract »|Full Text »|PDF »
MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management.
A. J. Lowery, N. Miller, R. E. McNeill, and M. J. Kerin (2008)
Clin. Cancer Res.
14, 360-365
|Abstract »|Full Text »|PDF »
Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells.
L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund (2008)
J. Biol. Chem.
283, 1026-1033
|Abstract »|Full Text »|PDF »
3' Terminal oligo U-tract-mediated stimulation of decapping.
Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing.
A. Eulalio, J. Rehwinkel, M. Stricker, E. Huntzinger, S.-F. Yang, T. Doerks, S. Dorner, P. Bork, M. Boutros, and E. Izaurralde (2007)
Genes & Dev.
21, 2558-2570
|Abstract »|Full Text »|PDF »
MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F.
G. Mathonnet, M. R. Fabian, Y. V. Svitkin, A. Parsyan, L. Huck, T. Murata, S. Biffo, W. C. Merrick, E. Darzynkiewicz, R. S. Pillai, et al. (2007)
Science
317, 1764-1767
|Abstract »|Full Text »|PDF »
Isolation of microRNA targets by miRNP immunopurification.
The role of GW/P-bodies in RNA processing and silencing.
A. Jakymiw, K. M. Pauley, S. Li, K. Ikeda, S. Lian, T. Eystathioy, M. Satoh, M. J. Fritzler, and E. K. L. Chan (2007)
J. Cell Sci.
120, 1317-1323
|Abstract »|Full Text »|PDF »